Published in JAMA on November 23, 2011
Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ (2013) 5.78
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 3.63
Lower levels of sodium intake and reduced cardiovascular risk. Circulation (2014) 3.39
Sodium Excretion and the Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease. JAMA (2016) 3.33
Urinary sodium excretion and kidney failure in nondiabetic chronic kidney disease. Kidney Int (2014) 2.86
Dietary sodium content, mortality, and risk for cardiovascular events in older adults: the Health, Aging, and Body Composition (Health ABC) Study. JAMA Intern Med (2015) 2.69
Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence. Mayo Clin Proc (2013) 2.42
Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ (2013) 2.28
Using Decomposition Analysis to Identify Modifiable Racial Disparities in the Distribution of Blood Pressure in the United States. Am J Epidemiol (2015) 1.80
Understanding the patterns and trends of sodium intake, potassium intake, and sodium to potassium ratio and their effect on hypertension in China. Am J Clin Nutr (2013) 1.50
Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention. J Am Coll Cardiol (2016) 1.49
Potassium urinary excretion and dietary intake: a cross-sectional analysis in 8-10 year-old children. BMC Pediatr (2015) 1.40
Foods and dietary patterns that are healthy, low-cost, and environmentally sustainable: a case study of optimization modeling for New Zealand. PLoS One (2013) 1.26
Diagnostic tools for hypertension and salt sensitivity testing. Curr Opin Nephrol Hypertens (2013) 1.21
Validity of predictive equations for 24-h urinary sodium excretion in adults aged 18-39 y. Am J Clin Nutr (2013) 1.19
Agreement between 24-hour salt ingestion and sodium excretion in a controlled environment. Hypertension (2015) 1.12
The wrong white crystals: not salt but sugar as aetiological in hypertension and cardiometabolic disease. Open Heart (2014) 1.01
Measurement error corrected sodium and potassium intake estimation using 24-hour urinary excretion. Hypertension (2013) 1.01
Population-wide sodium reduction: the bumpy road from evidence to policy. Ann Epidemiol (2012) 0.99
Potassium and health. Adv Nutr (2013) 0.98
Dietary salt intake and hypertension. Electrolyte Blood Press (2014) 0.96
Estimation of 24-hour urinary sodium excretion using spot urine samples. Nutrients (2014) 0.96
Food Consumption and its Impact on Cardiovascular Disease: Importance of Solutions Focused on the Globalized Food System: A Report From the Workshop Convened by the World Heart Federation. J Am Coll Cardiol (2015) 0.95
Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease. Curr Opin Nephrol Hypertens (2014) 0.94
The significance of duration and amount of sodium reduction intervention in normotensive and hypertensive individuals: a meta-analysis. Adv Nutr (2015) 0.93
Use of Urine Biomarkers to Assess Sodium Intake: Challenges and Opportunities. Annu Rev Nutr (2015) 0.93
Socioeconomic status is significantly associated with dietary salt intakes and blood pressure in Japanese workers (J-HOPE Study). Int J Environ Res Public Health (2013) 0.92
Neurogenic and sympathoexcitatory actions of NaCl in hypertension. Curr Hypertens Rep (2013) 0.92
Projected impact of a sodium consumption reduction initiative in Argentina: an analysis from the CVD policy model--Argentina. PLoS One (2013) 0.91
Dietary salt intake exaggerates sympathetic reflexes and increases blood pressure variability in normotensive rats. Hypertension (2014) 0.91
Scaling up chronic disease prevention interventions in lower- and middle-income countries. Annu Rev Public Health (2013) 0.91
Strategies to reduce dietary sodium intake. Curr Treat Options Cardiovasc Med (2012) 0.90
Effects of renal sympathetic denervation on urinary sodium excretion in patients with resistant hypertension. Clin Res Cardiol (2015) 0.89
Flawed evidence should not derail sound policy: the case remains strong for population-wide sodium reduction. Am J Hypertens (2013) 0.89
Common variants of the G protein-coupled receptor type 4 are associated with human essential hypertension and predict the blood pressure response to angiotensin receptor blockade. Pharmacogenomics J (2015) 0.89
A linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt sensitivity of blood pressure in exfoliated human renal proximal tubule cells: the virtual renal biopsy. Clin Chim Acta (2013) 0.88
Recent economic evaluations of interventions to prevent cardiovascular disease by reducing sodium intake. Curr Atheroscler Rep (2013) 0.87
Urinary Sodium and Potassium Excretion and CKD Progression. J Am Soc Nephrol (2015) 0.86
Improving the efficacy of RAAS blockade in patients with chronic kidney disease. Nat Rev Nephrol (2012) 0.85
Low-protein diets for chronic kidney disease patients: the Italian experience. BMC Nephrol (2016) 0.85
Urinary sodium and cardiovascular disease risk: informing guidelines for sodium consumption. JAMA (2011) 0.84
Low-Salt Diet and Circadian Dysfunction Synergize to Induce Angiotensin II-Dependent Hypertension in Mice. Hypertension (2016) 0.84
Dietary salt reduction and cardiovascular disease rates in India: a mathematical model. PLoS One (2012) 0.84
Salt intake and the association with blood pressure in young Iranian children: first report from the middle East and north Africa. Int J Prev Med (2013) 0.84
Congestive heart failure adherence redesign trial: a pilot study. BMJ Open (2014) 0.83
The science upon which to base dietary sodium policy. Adv Nutr (2014) 0.83
Whole grains, type 2 diabetes, coronary heart disease, and hypertension: links to the aleurone preferred over indigestible fiber. Biofactors (2013) 0.82
Cardiovascular disease: salt and cardiovascular risk. Nat Rev Nephrol (2012) 0.82
Expansion of the National Salt Reduction Initiative: A Mathematical Model of Benefits and Risks of Population-Level Sodium Reduction. Med Decis Making (2015) 0.82
Estimation of daily salt intake through a 24-hour urine collection in Pohang, Korea. J Korean Med Sci (2014) 0.82
"Dietaly": practical issues for the nutritional management of CKD patients in Italy. BMC Nephrol (2016) 0.82
Assessing the associations of sodium intake with long-term all-cause and cardiovascular mortality in a hypertensive cohort. Am J Hypertens (2014) 0.82
Association of urinary sodium-to-potassium ratio with obesity in a multiethnic cohort. Am J Clin Nutr (2014) 0.81
What determines human sodium intake: policy or physiology? Adv Nutr (2014) 0.81
Long-term dietary sodium restriction increases adiponectin expression and ameliorates the proinflammatory adipokine profile in obesity. Nutr Metab Cardiovasc Dis (2013) 0.81
Food Reformulation, Responsive Regulation, and "Regulatory Scaffolding": Strengthening Performance of Salt Reduction Programs in Australia and the United Kingdom. Nutrients (2015) 0.81
Normalisation of urinary biomarkers to creatinine for clinical practice and research--when and why. Singapore Med J (2015) 0.81
The management of orthostatic hypotension in Parkinson's disease. Front Neurol (2013) 0.80
Urinary sodium excretion and dietary sources of sodium intake in Chinese postmenopausal women with prehypertension. PLoS One (2014) 0.80
Sodium intake in a cross-sectional, representative sample of New York City adults. Am J Public Health (2014) 0.79
Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function. Clin J Am Soc Nephrol (2015) 0.79
Effects of a behavioral intervention that emphasizes spices and herbs on adherence to recommended sodium intake: results of the SPICE randomized clinical trial. Am J Clin Nutr (2015) 0.78
Dietary sodium and potassium intake is not associated with elevated blood pressure in US adults with no prior history of hypertension. J Clin Hypertens (Greenwich) (2014) 0.78
The feasibility of achieving low-sodium intake in diets that are also nutritious, low-cost, and have familiar meal components. PLoS One (2013) 0.78
Nutritional strategies for skeletal and cardiovascular health: hard bones, soft arteries, rather than vice versa. Open Heart (2016) 0.78
Exacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats. PLoS One (2014) 0.78
Interaction between Single Nucleotide Polymorphism and Urinary Sodium, Potassium, and Sodium-Potassium Ratio on the Risk of Hypertension in Korean Adults. Nutrients (2017) 0.77
Association of Urinary Sodium Excretion With Blood Pressure and Cardiovascular Clinical Events in 17,033 Latin Americans. Am J Hypertens (2015) 0.77
Associations between serum potassium and sodium levels and risk of hypertension: a community-based cohort study. J Geriatr Cardiol (2015) 0.77
Salt, blood pressure and cardiovascular risk: what is the most adequate preventive strategy? A Swiss perspective. Front Physiol (2015) 0.77
Serum Sodium and Potassium Levels in Cerebro-vascular Accident Patients. Malays J Med Sci (2013) 0.77
Lower potassium intake is associated with increased wave reflection in young healthy adults. Nutr J (2014) 0.77
High sodium intake: review of recent issues on its association with cardiovascular events and measurement methods. Korean Circ J (2015) 0.77
Making Sense of the Science of Sodium. Nutr Today (2015) 0.77
Identifying predictors of high sodium excretion in patients with heart failure: a mixed effect analysis of longitudinal data. Eur J Cardiovasc Nurs (2013) 0.76
Water and sodium in heart failure: a spotlight on congestion. Heart Fail Rev (2015) 0.76
What level of sodium intake worsens renal outcomes? Am J Hypertens (2014) 0.76
Cardiovascular disease in CKD in 2012: moving forward, slowly but surely. Nat Rev Nephrol (2013) 0.76
25 by 25: Achieving Global Reduction in Cardiovascular Mortality. Curr Cardiol Rep (2016) 0.76
Diagnostic status of hypertension on the adherence to the Dietary Approaches to Stop Hypertension (DASH) diet. Prev Med Rep (2016) 0.75
The pursuit of ideal cardiovascular health: an individual and societal challenge. Mayo Clin Proc (2012) 0.75
Dietary potassium intake and renal handling, and their impact on the cardiovascular health of normotensive afro-caribbeans. West Indian Med J (2014) 0.75
Dietary and lifestyle factors in hypertension. J Hum Hypertens (2016) 0.75
Gestation-specific reference intervals for comprehensive spot urinary steroid hormone metabolite analysis in normal singleton pregnancy and 6 weeks postpartum. Reprod Biol Endocrinol (2015) 0.75
Urinary sodium excretion and cardiovascular events. JAMA (2012) 0.75
Occupational Disparities in the Association between Self-Reported Salt-Eating Habit and Hypertension in Older Adults in Xiamen, China. Int J Environ Res Public Health (2016) 0.75
Impact of light salt substitution for regular salt on blood pressure of hypertensive patients. Arq Bras Cardiol (2014) 0.75
Association of estimated sodium and potassium intake with blood pressure in patients with systemic lupus erythematosus. Lupus (2016) 0.75
Low Response of Renin-Angiotensin System to Sodium Intake Intervention in Chinese Hypertensive Patients. Medicine (Baltimore) (2016) 0.75
Invited commentary: Quantifying salt in urine--a complex solution. Am J Epidemiol (2013) 0.75
The relevance of dietary sodium in hemodialysis. Nephrol Dial Transplant (2012) 0.75
Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease. Kidney Int (2016) 0.75
Dietary Sodium: Where Science and Policy Diverge. Am J Hypertens (2014) 0.75
Meta-Analysis of Potassium Intake and the Risk of Stroke. J Am Heart Assoc (2016) 0.75
Association of Urinary Sodium Excretion With Insulin Resistance in Korean Adolescents: Results From the Korea National Health and Nutrition Examination Survey 2009-2010. Medicine (Baltimore) (2016) 0.75
Urinary Sodium and Potassium Excretion and Carotid Atherosclerosis in Chinese Men and Women. Nutrients (2016) 0.75
Sodium restriction in heart failure: benefit or harm? Curr Treat Options Cardiovasc Med (2014) 0.75
Reported high salt intake is associated with increased prevalence of abdominal aortic aneurysm and larger aortic diameter in older men. PLoS One (2014) 0.75
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 42.12
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med (2008) 19.76
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2013) 18.17
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet (2005) 17.08
Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med (2010) 16.40
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med (1991) 16.19
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med (2011) 15.30
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet (2010) 14.40
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet (2008) 13.34
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet (2008) 13.15
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med (2009) 12.73
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med (2006) 11.72
Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med (2009) 11.49
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med (2012) 10.09
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet (2003) 9.98
Apixaban in patients with atrial fibrillation. N Engl J Med (2011) 9.97
Effect of ramipril on the incidence of diabetes. N Engl J Med (2006) 9.69
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ (2007) 9.10
Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med (2011) 8.93
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet (2011) 8.49
Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med (2015) 7.83
Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med (2014) 7.54
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA (2005) 7.35
Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet (2010) 7.08
Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA (2005) 6.81
Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med (2014) 6.65
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation (2011) 6.48
Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA (2007) 6.38
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med (2012) 6.16
Aspirin in patients undergoing noncardiac surgery. N Engl J Med (2014) 6.10
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med (2008) 6.08
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med (2010) 6.05
Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet (2006) 5.85
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation (2002) 5.79
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy. N Engl J Med (2015) 5.31
Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet (2008) 5.27
Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med (2006) 5.24
Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA (2013) 5.19
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet (2004) 5.19
Use of ramipril in preventing stroke: double blind randomised trial. BMJ (2002) 4.91
Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med (2014) 4.88
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87
Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med (2014) 4.86
Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med (2009) 4.83
Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol (2007) 4.74
Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. N Engl J Med (2010) 4.73
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens (2007) 4.59
Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA (2012) 4.58
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med (2010) 4.52
Defining obesity cut points in a multiethnic population. Circulation (2007) 4.42
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol (2005) 4.40
Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet (2008) 4.37
Need for expertise based randomised controlled trials. BMJ (2005) 4.34
Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial. Circulation (2012) 4.33
Off-pump or on-pump coronary-artery bypass grafting at 30 days. N Engl J Med (2012) 4.32
Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. N Engl J Med (2013) 4.27
Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation (2005) 4.21
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation (2006) 3.85
The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res (2006) 3.80
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet (2015) 3.79